ReviewHypertension research : official journal of the Japanese Society of Hypertension2026
A scoping review of salt reduction guidance for the food industry.
Review in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this scoping review, we aimed to identify existing salt-reduction guidance for the food industry to support food companies seeking to reduce salt levels in their products. The search was conducted on PubMed and Google by two investigators. We extracted the common characteristics of the guidance. Of the 387 websites and 20 pieces of literature reviewed, four guidance documents were identified. All the extracted guidance documents included the background of the guidance development, current sodium intake, and target amounts. The background of the development of these guidance documents in various countries included reports that excessive salt intake increases the risk of diseases and healthcare costs, and that educational initiatives alone have limited effectiveness in reducing salt intake. Sodium intake exceeded the targets in most regions, largely due to processed foods. Of the four guidance documents, three were published by government agencies and one by the food industry. Three documents (Canada, the United States, and the United Kingdom) primarily function as category-specific sodium reduction target frameworks for industry, whereas the European document developed by FoodDrinkEurope provides more practice-oriented guidance focusing on reformulation strategies. The target intake levels were set at 5.1-7.0 g/day, with timelines spanning 3-5 years. This review may serve as a reference for the food industry in countries with excessive salt intake to facilitate the development of strategies for reducing salt consumption.
Indexed as
Identifiers
42811151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.